
DiaSorin
Price
Price
CHART BY
Historical dividends and forecast
DiaSorin has so far distributed $1.359 in 2025. The next dividend will be paid on 21.05.2026
CHART BY
Frequently asked questions
What is DiaSorin's market capitalization?
What is DiaSorin's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for DiaSorin?
What are the analyst ratings and target price for DiaSorin's stock?
What is DiaSorin's revenue over the trailing twelve months?
What is the EBITDA for DiaSorin?
What is the free cash flow of DiaSorin?
How many employees does DiaSorin have, and what sector and industry does it belong to?
What is the free float of DiaSorin's shares?
Financials
- Market Cap
- $4.06B
- EPS (TTM)
- $4.16
- Free Float
- 21.10M
- P/E ratio (TTM)
- 18.11
- Revenue (TTM)
- $1.42B
- EBITDA (TTM)
- $503.04M
- Free Cashflow (TTM)
- $346.70M
Pricing
- 1D span
- $74.42$75.70
- 52W span
- $67.15$114.82
Analyst Ratings
The price target is $100.78 and the stock is covered by 15 analysts.
Buy
10
Hold
4
Sell
1
Information
DiaSorin SpA engages in developing, producing and marketing reagent kits for laboratory diagnostics. It operates through following segments Immunodiagnostics, Molecular Diagnostics, and Life Science. The Immunodiagnostics segment engages in the development of new tests based on complex algorithms. The Molecular Diagnostics segment focuses on providing specialty tests and complex multiplex solutions. The Life Science segment offers diagnostic instruments and technology. The firm provides clinical services in areas like Infectious diseases, bone and mineral, endocrinology, hypertension, oncology, stool diagnostics and autoimmunity. The company was founded in 1968 and is headquartered in Saluggia, Italy.
- Employees
- 3,271
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- IT0003492391
- Primary Ticker
- DIA